cbdMD, Inc. (YCBD)

cbdMD Statistics

Total Valuation

cbdMD has a market cap or net worth of $759,368. The enterprise value is $139,239.

Market Cap	759,368
Enterprise Value	139,239

Important Dates

The last earnings date was Thursday, May 15, 2025, after market close.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

cbdMD has 782,854 shares outstanding. The number of shares has increased by 95.06% in one year.

Current Share Class	782,854
Shares Outstanding	782,854
Shares Change (YoY)	+95.06%
Shares Change (QoQ)	+36.80%
Owned by Insiders (%)	19.85%
Owned by Institutions (%)	5.95%
Float	466,349

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.03
Forward PS	0.07
PB Ratio	1.15
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.01
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.63, with a Debt / Equity ratio of 1.72.

Current Ratio	0.63
Quick Ratio	0.29
Debt / Equity	1.72
Debt / EBITDA	0.66
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -8.46% and return on invested capital (ROIC) is -14.91%.

Return on Equity (ROE)	-8.46%
Return on Assets (ROA)	-6.23%
Return on Invested Capital (ROIC)	-14.91%
Return on Capital Employed (ROCE)	-119.21%
Revenue Per Employee	$466,503
Profits Per Employee	-$99,113
Employee Count	42
Asset Turnover	1.54
Inventory Turnover	2.33

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.71% in the last 52 weeks. The beta is 2.77, so cbdMD's price volatility has been higher than the market average.

Beta (5Y)	2.77
52-Week Price Change	-81.71%
50-Day Moving Average	1.66
200-Day Moving Average	3.27
Relative Strength Index (RSI)	33.91
Average Volume (20 Days)	181,791

Short Selling Information

The latest short interest is 102,825, so 13.13% of the outstanding shares have been sold short.

Short Interest	102,825
Short Previous Month	55,488
Short % of Shares Out	13.13%
Short % of Float	22.05%
Short Ratio (days to cover)	0.70

Income Statement

In the last 12 months, cbdMD had revenue of $19.59 million and -$4.16 million in losses. Loss per share was -$6.06.

Revenue	19.59M
Gross Profit	12.22M
Operating Income	-1.27M
Pretax Income	-21.65M
Net Income	-4.16M
EBITDA	-111,230
EBIT	-1.27M
Loss Per Share	-$6.06

Balance Sheet

The company has $1.77 million in cash and $1.15 million in debt, giving a net cash position of $620,129 or $0.79 per share.

Cash & Cash Equivalents	1.77M
Total Debt	1.15M
Net Cash	620,129
Net Cash Per Share	$0.79
Equity (Book Value)	665,798
Book Value Per Share	0.84
Working Capital	-3.68M

Cash Flow

In the last 12 months, operating cash flow was -$50,270 and capital expenditures -$189,893, giving a free cash flow of -$240,163.

Operating Cash Flow	-50,270
Capital Expenditures	-189,893
Free Cash Flow	-240,163
FCF Per Share	-$0.31

Margins

Gross margin is 62.35%, with operating and profit margins of -6.49% and -0.81%.

Gross Margin	62.35%
Operating Margin	-6.49%
Pretax Margin	-0.81%
Profit Margin	-0.81%
EBITDA Margin	-0.57%
EBIT Margin	-6.49%
FCF Margin	n/a

Dividends & Yields

cbdMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-95.06%
Shareholder Yield	-95.06%
Earnings Yield	-548.18%
FCF Yield	-31.63%

Analyst Forecast

The average price target for cbdMD is $3.00, which is 209.28% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$3.00
Price Target Difference	209.28%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on May 7, 2025. It was a reverse split with a ratio of 0.125:1.

Last Split Date	May 7, 2025
Split Type	Reverse
Split Ratio	0.125:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2